Compass Pathways

Studies show psilocybin therapy has potential for anorexia nervosa and severe treatment-resistant depression

Positive Early Signals Seen in Two Investigator-Initiated Studies Presented at the Society of Biological Psychiatry Annual Meeting in New Orleans COMPASS Pathways (COMPASS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that positive data two investigator-initiated studies demonstrating the potential of COMP360 psilocybin therapy in anorexia …

Studies show psilocybin therapy has potential for anorexia nervosa and severe treatment-resistant depression Read More »

PSYCH Publishes Third Edition of The Psychedelics as Medicine Report

PSYCH, the premium business-to-business media and content platform for the psychedelic science and healthcare industry, today announced the release of the third issue of its flagship publication, The Psychedelics as Medicine Report. The Psychedelics as Medicine Report is the most comprehensive account of the global psychedelics industry, with unparalleled market intelligence and insights empowering investors, …

PSYCH Publishes Third Edition of The Psychedelics as Medicine Report Read More »

Leaders in Psychedelic Medicine Join to Form Psychedelic Medicine Association

The Psychedelic Medicine Association (PMA) Aims to Bridge the Gap Between the Medical Establishment, Patients, and Industry Leaders As psychedelic medicines progress through clinical trial pathways and legislation is amended, patients are starting to ask doctors, psychologists, and psychiatrists about access to ground breaking new treatments. “We want physicians and other healthcare providers to feel …

Leaders in Psychedelic Medicine Join to Form Psychedelic Medicine Association Read More »

A Review of Psychedelic Plant Medicine Studies in Canada

Canada Plays a Significant Role in the Research of Natural Psychedelic Plant Medicine. The study of plant medicine and psychedelic plants gets a back seat when it comes to legal research and clinical trials. This is compared to the ease and simplicity of focusing on a psychedelic molecule, plant derivative, or a plant-based proprietary medicine, …

A Review of Psychedelic Plant Medicine Studies in Canada Read More »

Scroll to Top